| P2093 | author name string | Zhiyong Chen | |
| | Fanhang Meng | |
| | Minzhuan Lin | |
| | SiYang Chen | |
| | Xianen Huang | |
| | Xuekun Guo | |
| | Yongtong Lai | |
| P2860 | cites work | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 |
| | Interleukin-17 family members and inflammation | Q28287876 |
| | A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 |
| | Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice | Q33968062 |
| | Th17/Treg ratio in human graft-versus-host disease. | Q34403757 |
| | Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 |
| | Regulatory T cells in transplantation tolerance | Q35092535 |
| | IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. | Q35402371 |
| | The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease | Q36747499 |
| | T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 |
| | Regulatory myeloid suppressor cells in health and disease | Q37373257 |
| | TH17 cells and regulatory T cells in primary immunodeficiency diseases | Q37467739 |
| | IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma. | Q39024081 |
| | The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. | Q44578886 |
| | The Th17/Treg imbalance in patients with acute coronary syndrome | Q46737661 |
| | Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 |
| | Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. | Q53087524 |
| | Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. | Q54453217 |
| | Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. | Q54622675 |
| | Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 |
| | Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine | Q60311223 |
| | Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 |
| | Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion | Q81394821 |
| | Clinical significance of the ratio between FOXP3 positive regulatory T cell and interleukin-17 secreting cell in renal allograft biopsies with acute T-cell-mediated rejection | Q83736775 |
| P433 | issue | 5 | |
| P304 | page(s) | 1799-1805 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Inflammation | Q2560341 |
| P1476 | title | Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection. | |
| P478 | volume | 37 | |